ABS Capital Closes First Continuation Fund
WASHINGTON--(BUSINESS WIRE)--ABS Capital (“ABS”), a leading growth equity firm with over three decades of experience scaling software and tech-enabled B2B businesses, is pleased to announce the completion of a GP-led secondary transaction centered around two of its portfolio companies, LabConnect, Inc. (“LabConnect”...
Source: pharmiweb.com